Vaccine trials against COVID-19 are leading the effort before studies begin in children. This white paper describes the challenges facing COVID-19 pediatric clinical trials from protocol to planning of pediatric sites.

Key takeaways:

  • Why COVID-19 vaccine trials may be necessary for children in addition to ongoing adult trials.
  • What protocols are currently in place for pediatric trials and how that affects COVID-19 pediatric trials.
  • How to plan for pediatric sites in order to ensure safety for trial participants, staff, and other related entities.


When you need direct access to physicians and their known patients or research practice management solutions to accelerate your clinical trials, there’s Only Elligo.

Contact Us